Weinberg's Pharma Omnium sells Biodim subsidiary
France-based Pharma Omnium International, a portfolio company of Weinberg Capital Partners (WCP), has sold its subsidiary Laboratoire Biodim to pharmaceutical business NuPharm, backed by Apax Partners.
More on Exits
Connection Capital sells JCRA
Connection Capital provided £6.7m to support the buyout of the business in 2017
Keensight to buy Sogelink from Naxicap
GP returns to the French software provider, which it owned from 2013 to 2016
FSN sells 25% stake in Bygghemma to EQT
FSN will remain the largest shareholder in the listed Swedish interior design retailer
FSN acquires Impreg from BWB Partners
Existing management team will reinvest alongside FSN and continue to own a stake
Latest News
Idinvest passes €500m mark in Private Debt V fundraise
Fund, which has already been invested in at least one transaction, has a €1bn target
Pechel, Ommes back Jems Group MBO
Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm
Connection Capital sells JCRA
Connection Capital provided £6.7m to support the buyout of the business in 2017
Temasek, SIB in $18m series-B for PureLiFi
Temasek previously led a £7m investment for the technology developer in 2016